- Home
- GVH vs HSCS Comparison
GVH vs HSCS Comparison
Compare GVH & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GVH | HSCS |
|---|---|---|
| Founded | 2016 | 2007 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8M | 7.5M |
| IPO Year | 2023 | 2022 |
Fundamental Metrics
Financial Performance| Metric | GVH | HSCS |
|---|---|---|
| Price | $3.22 | $2.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $80.00 | $10.50 |
| AVG Volume (30 Days) | 51.1K | ★ 67.8K |
| Earning Date | 09-09-2025 | 12-15-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 11.95 | N/A |
| Revenue | ★ $21,878,867.00 | $8,669.00 |
| Revenue This Year | $141,706.20 | N/A |
| Revenue Next Year | $3.35 | N/A |
| P/E Ratio | $0.27 | ★ N/A |
| Revenue Growth | ★ 24.52 | N/A |
| 52 Week Low | $2.95 | $2.01 |
| 52 Week High | $364.00 | $6.47 |
Technical Indicators
Market Signals| Indicator | GVH | HSCS |
|---|---|---|
| Relative Strength Index (RSI) | 38.25 | 40.20 |
| Support Level | $2.95 | $2.55 |
| Resistance Level | $4.03 | $2.83 |
| Average True Range (ATR) | 0.30 | 0.21 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 19.41 | 22.62 |
Price Performance
Historical ComparisonAbout GVH Globavend Holdings Limited
Globavend Holdings Ltd is an e-commerce logistics provider, it provides integrated cross-border logistics services from Hong Kong to Australia and New Zealand, where it provides customers with a one-stop solution from parcel consolidation to air freight forwarding, customs clearance, on-carriage parcel transportation and delivery. It operates in logistics and freight forwarding industry, which involves the provision of services such as freight transport, freight forwarding, warehouse management, and distribution.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.